The vicious cycle between (neuro)inflammation and alcohol use disorder: An opportunity to develop new medications?

被引：2
|
作者：
Leko, Andras H. [1 ,2 ,3 ]
Ray, Lara A. [4 ,5 ]
Leggio, Lorenzo [1 ,2 ,6 ,7 ,8 ]
机构：
[1] NIDA, Clin Psychoneuroendocrinol & Neuropsychopharmacol, Translat Addict Med Branch, Intramural Res Program,NIH, Bethesda, MD 20892 USA
[2] NIAAA, Div Intramural Clin & Biol Res, NIH, Bethesda, MD 20892 USA
[3] NIH, Ctr Compuls Behav, Intramural Res Program, Bethesda, MD USA
[4] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA
[5] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA
[6] Brown Univ, Ctr Alcohol & Addict Studies, Dept Behav & Social Sci, Providence, RI USA
[7] Johns Hopkins Univ, Sch Med, Dept Med, Div Addict Med, Baltimore, MD USA
[8] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC USA
来源：
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH | 2023年 / 47卷 / 05期
关键词：
RECEPTOR; NEUROINFLAMMATION; EXPRESSION; DRINKING;
D O I：
10.1111/acer.15049
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：843 / 847
页数：5
相关论文
共 50 条
  • [21] Neuroimaging of inflammation in alcohol use disorder: a review
    Feldman, Dana E.
    McPherson, Katherine L.
    Biesecker, Catherine L.
    Wiers, Corinde E.
    Manza, Peter
    Volkow, Nora D.
    Wang, Gene-Jack
    SCIENCE CHINA-INFORMATION SCIENCES, 2020, 63 (07)
  • [22] Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease
    Luo, Yunfei
    Lin, Hui
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (01) : 59 - 73
  • [23] The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: A vicious cycle
    Cai, Yu
    Zhang, Yangqiqi
    Leng, Shuo
    Ma, Yuanyuan
    Jiang, Quan
    Wen, Qiuting
    Ju, Shenghong
    Hu, Jiani
    NEUROBIOLOGY OF DISEASE, 2024, 192
  • [24] Adherence to FDA-Approved Medications for Alcohol Use Disorder
    Blalock, D., V
    Woolson, S.
    Burns, M.
    Bosworth, H. B.
    Dedert, E. A.
    Calhoun, P. S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (01)
  • [25] Applying Behavioral Economics to Screen Medications for Alcohol Use Disorder
    Nieto, Steven
    MacKillop, James
    Izquierdo, Alicia
    Ray, Lara
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 463 - 463
  • [26] Overcoming the "Valley of Death" in Medications Development for Alcohol Use Disorder
    Ray, Lara A.
    Bujarski, Spencer
    Roche, Daniel James Olan
    Magill, Molly
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 (09) : 1612 - 1622
  • [27] Medications to Treat Alcohol Use Disorder: Targeting the Dark Side
    Mason, Barbara J.
    AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (05): : 375 - 377
  • [28] Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
    Abraham, Amanda J.
    Andrews, Christina M.
    Harris, Samantha J.
    Friedmann, Peter D.
    NEUROTHERAPEUTICS, 2020, 17 (01) : 55 - 69
  • [29] Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
    Amanda J. Abraham
    Christina M. Andrews
    Samantha J. Harris
    Peter D. Friedmann
    Neurotherapeutics, 2020, 17 : 55 - 69
  • [30] Clinician Prescribing Practices Involving Medications for Alcohol Use Disorder
    Kennedy-Hendricks, Alene
    Busch, Alisa B.
    Azeni, Hocine
    Horgan, Constance M.
    Uscher-Pines, Lori
    Hodgkin, Dominic
    Huskamp, Haiden A.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2025, 68 (03) : 446 - 454
12345